Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain. Issue 10 (25th September 2017)

• Record Type: Journal Article
• Authors: Genoud, Sian; Roberts, Blaine R.; Gunn, Adam P.; Halliday, Glenda M.; Lewis, Simon J. G.; Ball, Helen J.; Hare, Dominic J.; Double, Kay L.
• Is Part Of: Metallomics. Volume 9:Issue 10(2017)
• Page Start: 1447
• Page End: 1455
• Publication Date: 2017-09-25
• Subjects: Metals -- Physiological effect -- Periodicals; 572.51
• DOI: 10.1039/c7mt00244k
• Languages: English
• ISSNs: 1756-5901

Abstract

Abstract : Altered iron and copper levels in the Parkinson's disease substantia nigra are confined to the cytosolic compartment of the cell. Abstract : Elevated iron and decreased copper levels are cardinal features of the degenerating substantia nigra pars compacta in the Parkinson's disease brain. Both of these redox-active metals, and fellow transition metals manganese and zinc, are found at high concentrations within the midbrain and participate in a range of unique biological reactions. We examined the total metal content and cellular compartmentalisation of manganese, iron, copper and zinc in the degenerating substantia nigra, disease-affected but non-degenerating fusiform gyrus, and unaffected occipital cortex in the post mortem Parkinson's disease brain compared with age-matched controls. An expected increase in iron and a decrease in copper concentration was isolated to the soluble cellular fraction, encompassing both interstitial and cytosolic metals and metal-binding proteins, rather than the membrane-associated or insoluble fractions. Manganese and zinc levels did not differ between experimental groups. Altered Fe and Cu levels were unrelated to Braak pathological staging in our cases of late-stage (Braak stage V and VI) disease. The data supports our hypothesis that regional alterations in Fe and Cu, and in proteins that utilise these metals, contribute to the regional selectively of neuronal vulnerability in this disorder.